Pregnancy Rate Determined by Pearl Index Cycle 6 (Day 168) [clinicaltrials_resource:0d0d4eea8c30bf62b5ad6e24c7180866]

Pearl Index is the number of pregnancies with use of therapy divided by the number of cycles with therapy use. It is an estimation of the number of pregnancies per 100 woman-years of product use.

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

Primary outcome [clinicaltrials_vocabulary:primary-outcome]

http://bio2rdf.org/clinicaltrials_resource:0d0d4eea8c30bf62b5ad6e24c7180866

Pregnancy Rate Determined by Pearl Index Cycle 6 (Day 168) [clinicaltrials_resource:0d0d4eea8c30bf62b5ad6e24c7180866]

Bio2RDF uri

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol [clinicaltrials:NCT00307632]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Pregnancy Rate Determined by Pearl Index Cycle 6 (Day 168) [clinicaltrials_resource:0d0d4eea8c30bf62b5ad6e24c7180866]

Pearl Index is the number of pregnancies with use of therapy divided by the number of cycles with therapy use. It is an estimation of the number of pregnancies per 100 woman-years of product use.

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

Primary outcome [clinicaltrials_vocabulary:primary-outcome]

http://bio2rdf.org/clinicaltrials_resource:0d0d4eea8c30bf62b5ad6e24c7180866